Clinical Report: Addressing Obstacles to Autism Diagnosis for Latine Children
Overview
This study identifies significant barriers faced by Latine children with limited English proficiency in obtaining timely autism diagnoses, including language discordance and cultural stigma. It highlights the need for structural adaptations in diagnostic care models to better serve Spanish-speaking families.
Background
Latine children often experience delays in autism diagnosis, leading to health inequities and poorer developmental outcomes. Barriers include language discordance, cultural stigma, and systemic issues within healthcare. Understanding these challenges is crucial for developing equitable diagnostic services.
Data Highlights
Qualitative and quantitative data were collected from caregivers, clinicians, and care coordinators to identify barriers and strategies for improving autism diagnostic services for Latine families, revealing significant delays in diagnosis and communication challenges.
Key Findings
Significant lag exists between caregivers' first developmental concerns and the autism diagnosis.
Language discordance and interpreter quality issues are major barriers in clinician-patient interactions.
Caregivers report social isolation and mistrust of health systems, exacerbated by immigration-related stressors.
Clinicians acknowledge challenges in communicating about autism with Spanish-speaking families.
Structural barriers include high service costs and limited transportation access.
Clinical Implications
Healthcare providers should recognize the unique challenges faced by Latine families in accessing autism diagnostic services.
Conclusion
Addressing the barriers to autism diagnosis for Latine children requires a comprehensive approach that includes cultural competence and systemic changes.
by Ann Marie Martin, Gisela Perez, Elizabeth Frances Battle, Aaliyah Saunders, Stephanie Pozuelos, Mary Ciccarelli, Angela Paxton, Carrie Leathers, Rebecca McNally Keehn
Systematic review of 8 observational studies found limited evidence on associations between prenatal asthma-medication exposure and neurodevelopmental outcomes, with autism spectrum disorder the only outcome suitable for meta-analysis.